Cargando…

Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis

Multiple Sclerosis (MS) has been reported to be associated with intestinal inflammation and gut dysbiosis. To elucidate the underlying biology of MS-linked gut inflammation, we investigated gut infiltration of immune cells during the development of spontaneous experimental autoimmune encephalomyelit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Sudhir K., Ito, Naoko, Mindur, John E., Kumar, Hetal, Youssef, Mysra, Suresh, Shradha, Kulkarni, Ratuja, Rosario, Yaritza, Balashov, Konstantin E., Dhib-Jalbut, Suhayl, Ito, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634083/
https://www.ncbi.nlm.nih.gov/pubmed/36341389
http://dx.doi.org/10.3389/fimmu.2022.1015372
_version_ 1784824389657690112
author Yadav, Sudhir K.
Ito, Naoko
Mindur, John E.
Kumar, Hetal
Youssef, Mysra
Suresh, Shradha
Kulkarni, Ratuja
Rosario, Yaritza
Balashov, Konstantin E.
Dhib-Jalbut, Suhayl
Ito, Kouichi
author_facet Yadav, Sudhir K.
Ito, Naoko
Mindur, John E.
Kumar, Hetal
Youssef, Mysra
Suresh, Shradha
Kulkarni, Ratuja
Rosario, Yaritza
Balashov, Konstantin E.
Dhib-Jalbut, Suhayl
Ito, Kouichi
author_sort Yadav, Sudhir K.
collection PubMed
description Multiple Sclerosis (MS) has been reported to be associated with intestinal inflammation and gut dysbiosis. To elucidate the underlying biology of MS-linked gut inflammation, we investigated gut infiltration of immune cells during the development of spontaneous experimental autoimmune encephalomyelitis (EAE) in humanized transgenic (Tg) mice expressing HLA-DR2a and human T cell receptor (TCR) specific for myelin basic protein peptide (MBP87-99)/HLA-DR2a complexes. Strikingly, we noted the simultaneous development of EAE and colitis, suggesting a link between autoimmune diseases of the central nervous system (CNS) and intestinal inflammation. Examination of the colon in these mice revealed the infiltration of MBP-specific Th17 cells as well as recruitment of neutrophils. Furthermore, we observed that fecal Lipocalin-2 (Lcn-2), a biomarker of intestinal inflammation, was significantly elevated and predominantly produced by the gut-infiltrating neutrophils. We then extended our findings to MS patients and demonstrate that their fecal Lcn-2 levels are significantly elevated compared to healthy donors (HDs). The elevation of fecal Lcn-2 levels correlated with reduced bacterial diversity and increased levels of other intestinal inflammation markers including neutrophil elastase and calprotectin. Of interest, bacteria thought to be beneficial for inflammatory bowel disease (IBD) such as Anaerobutyricum, Blautia, and Roseburia, were reduced in fecal Lcn-2-high MS patients. We also observed a decreasing trend in serum acetate (a short-chain fatty acid) levels in MS Lcn-2-high patients compared to HDs. Furthermore, a decrease in the relative abundance of Blautia massiliensis was significantly associated with a reduction of acetate in the serum of MS patients. This study suggests that gut infiltration of Th17 cells and recruitment of neutrophils are associated with the development of gut dysbiosis and intestinal inflammation, and that fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis in multiple sclerosis.
format Online
Article
Text
id pubmed-9634083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96340832022-11-05 Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis Yadav, Sudhir K. Ito, Naoko Mindur, John E. Kumar, Hetal Youssef, Mysra Suresh, Shradha Kulkarni, Ratuja Rosario, Yaritza Balashov, Konstantin E. Dhib-Jalbut, Suhayl Ito, Kouichi Front Immunol Immunology Multiple Sclerosis (MS) has been reported to be associated with intestinal inflammation and gut dysbiosis. To elucidate the underlying biology of MS-linked gut inflammation, we investigated gut infiltration of immune cells during the development of spontaneous experimental autoimmune encephalomyelitis (EAE) in humanized transgenic (Tg) mice expressing HLA-DR2a and human T cell receptor (TCR) specific for myelin basic protein peptide (MBP87-99)/HLA-DR2a complexes. Strikingly, we noted the simultaneous development of EAE and colitis, suggesting a link between autoimmune diseases of the central nervous system (CNS) and intestinal inflammation. Examination of the colon in these mice revealed the infiltration of MBP-specific Th17 cells as well as recruitment of neutrophils. Furthermore, we observed that fecal Lipocalin-2 (Lcn-2), a biomarker of intestinal inflammation, was significantly elevated and predominantly produced by the gut-infiltrating neutrophils. We then extended our findings to MS patients and demonstrate that their fecal Lcn-2 levels are significantly elevated compared to healthy donors (HDs). The elevation of fecal Lcn-2 levels correlated with reduced bacterial diversity and increased levels of other intestinal inflammation markers including neutrophil elastase and calprotectin. Of interest, bacteria thought to be beneficial for inflammatory bowel disease (IBD) such as Anaerobutyricum, Blautia, and Roseburia, were reduced in fecal Lcn-2-high MS patients. We also observed a decreasing trend in serum acetate (a short-chain fatty acid) levels in MS Lcn-2-high patients compared to HDs. Furthermore, a decrease in the relative abundance of Blautia massiliensis was significantly associated with a reduction of acetate in the serum of MS patients. This study suggests that gut infiltration of Th17 cells and recruitment of neutrophils are associated with the development of gut dysbiosis and intestinal inflammation, and that fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis in multiple sclerosis. Frontiers Media S.A. 2022-10-21 /pmc/articles/PMC9634083/ /pubmed/36341389 http://dx.doi.org/10.3389/fimmu.2022.1015372 Text en Copyright © 2022 Yadav, Ito, Mindur, Kumar, Youssef, Suresh, Kulkarni, Rosario, Balashov, Dhib-Jalbut and Ito https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yadav, Sudhir K.
Ito, Naoko
Mindur, John E.
Kumar, Hetal
Youssef, Mysra
Suresh, Shradha
Kulkarni, Ratuja
Rosario, Yaritza
Balashov, Konstantin E.
Dhib-Jalbut, Suhayl
Ito, Kouichi
Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title_full Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title_fullStr Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title_full_unstemmed Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title_short Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
title_sort fecal lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634083/
https://www.ncbi.nlm.nih.gov/pubmed/36341389
http://dx.doi.org/10.3389/fimmu.2022.1015372
work_keys_str_mv AT yadavsudhirk fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT itonaoko fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT mindurjohne fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT kumarhetal fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT youssefmysra fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT sureshshradha fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT kulkarniratuja fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT rosarioyaritza fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT balashovkonstantine fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT dhibjalbutsuhayl fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis
AT itokouichi fecallcn2levelisasensitivebiologicalindicatorforgutdysbiosisandintestinalinflammationinmultiplesclerosis